Nebraska Cancer Specialties

Site:	Nebraska Cancer Specialties
Address:
City:	Omaha
State:	NE
Zip:	68130
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy	Not yet recruiting	Not yet activated	IDRX-42	NCT07218926